お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
925352

ヒアルロン酸ベースのダーマルフィラー(皮膚充填剤)の世界市場:成長、動向、予測(2020年~2025年)

Hyaluronic Acid Based Dermal Fillers Market - Growth, Trends, and Forecast (2020 - 2025)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 120 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=111.11円
ヒアルロン酸ベースのダーマルフィラー(皮膚充填剤)の世界市場:成長、動向、予測(2020年~2025年)
出版日: 2020年02月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 120 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

低侵襲のフェイシャルトリートメントへの需要の高まりやヒアルロン酸ベースの化粧品の適応などの要因は、予測期間中のヒアルロン酸ベースのダーマルフィラー(皮膚充填剤)市場の成長を後押しすると予想されます。また、美容整形手術の数の増加はさらに市場の成長を後押しします。

当レポートでは、世界のヒアルロン酸ベースのダーマルフィラー(皮膚充填剤)市場を調査し、市場の概要、製品・用途・エンドユーザー・地域別の市場規模の推移と予測、市場動向、市場の成長要因および阻害要因の分析、市場機会、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概要
  • 市場成長要因
    • 非侵襲的皮膚科技術と高齢化人口に対する需要の増加
    • 新しいヒアルロン酸ベースの皮膚充填剤のための研究開発投資の増加
  • 市場抑制要因
    • 熟練した技術者不足
    • 高いコスト
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤーの交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 競争の激化

第5章 市場セグメンテーション

  • 製品別
    • シングルフェイズ
    • デュプレックス
  • 用途別
    • しわ修正
    • 瘢痕治療
    • ボリュームの復元
    • 口唇拡大術 
    • その他
  • エンドユーザー別
    • 病院
    • 専門皮膚科クリニック
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ地域
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Allergan
    • Galderma SA
    • LG Chem Ltd.
    • MERZ PHARMACEUTICALS
    • Sinclair Pharma
    • Anika Therapeutics, Inc.
    • Teoxane SA
    • BioPlus Co., Ltd.
    • SCULPT Luxury Dermal Fillers LTD
    • Suneva Medical Inc.

第7章 市場機会および将来動向

目次
Product Code: 67901
  • Factors such as rising demand for minimally invasive facial treatments and adaptation of hyaluronic acid-based cosmetic products are expected to boost the market growth over the forecast period.
  • In addition, ageing population and advances in hyaluronic acid-based surgical techniques such as using ultrasound to increase the efficiency of treatment are anticipated to fuel the adaptation of the products.
  • Moreover, an increasing number of cosmetic surgeries worldwide expected to boost market growth over the forecast period.
  • According to the International Society of Aesthetic Plastic Surgery data, in 2018, there were 10,607,227 surgical procedure and 12,659,147 non-surgical procedures performed by the plastic surgeons worldwide.
  • However, lack of skilled professionals coupled with the high cost of dermal filling procedures expected to hamper the market growth.

Key Market Trends

Wrinkle Treatment expected to Register Significant Share

  • In the application segment, wrinkle treatment is projected to have significant share owing to growing customer awareness and ageing population around the world. According to the United Nations, 2017, the global population aged 60 and above has reached 962 million and expected to grow at significant rates over the coming years.
  • Moreover, advancements in hyaluronic acid-based dermal filling technologies for wrinkle treatment coupled with increasing spending on cosmetic surgeries is expected to boost the market growth over the forecast period.
  • Single-phase hyaluronic acid dermal fillers are expected to have notable growth rate owing to new product launches and their efficiency.
  • Moreover, single-phase dermal fillers have multiple applications and fewer side effects, which fuel the usage of the single-phase dermal fillers.

North America is Expected to have Significant Market Share

  • North America is projected to have significant market share owing to well-established healthcare infrastructure, favourable policies and a growing number of plastic surgery procedures in the region.
  • According to the International Society of Aesthetic Plastic Surgery, the United States is the country with the highest number of plastic surgeons (7,009) in the United States.
  • According to the American Society of Plastic Surgeons, in 2018, there were 17.7 million surgical and minimally invasive plastic surgery procedures are performed in the United States.
  • Moreover, the high adoption of plastic surgeries and minimally invasive plastic surgery procedures expected to boost the regional growth
  • Due to the presence of a large number of older people in Europe, increasing demand for anti-ageing treatment and usage of dermal fillers fueling the regional market.

Competitive Landscape

Global hyaluronic acid-based dermal fillers market is moderately fragmented and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. For instance, Galderma has announced, it has received U.S. Food and Drug Administration for the use of a small blunt tip cannula with Restylane Silk dermal filler, The key market players operating in clot management devices market include Allergan plc, Galderma S.A., LG Chem Ltd., Merx Pharmaceuticals and Sinclair Pharma among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Non-Invasive Dermatology Techniques and Ageing Population
    • 4.2.2 Increasing R&D Investments for New Hyaluronic Acid Based Dermal Fillers
  • 4.3 Market Restraints
    • 4.3.1 Lack of Skilled Professionals
    • 4.3.2 High Cost of Dermal Filling Procedures
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Single Phase
    • 5.1.2 Duplex
  • 5.2 By Application
    • 5.2.1 Wrinkle Correction
    • 5.2.2 Scar Treatment
    • 5.2.3 Restoration of Volume
    • 5.2.4 Lip Augmentation
    • 5.2.5 Others
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Specialty Dermatology Clinics
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Allergan
    • 6.1.2 Galderma S.A.
    • 6.1.3 LG Chem Ltd.
    • 6.1.4 MERZ PHARMACEUTICALS
    • 6.1.5 Sinclair Pharma
    • 6.1.6 Anika Therapeutics, Inc.
    • 6.1.7 Teoxane S.A.
    • 6.1.8 BioPlus Co., Ltd.
    • 6.1.9 SCULPT Luxury Dermal Fillers LTD
    • 6.1.10 Suneva Medical Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.